Back to search

Article

Targeting lysosomal damage is a new therapeutic perspective for Duchenne Muscular Dystrophy

2025-02-13

Abstract excerpt

Duchenne Muscular Dystrophy (DMD), a muscle degenerative disease affecting young boys, arises from the loss of dystrophin. Current gene therapy approaches aim to restore a shortened form of dystrophin (microdystrophin) via Adeno-Associated Vector (AAV) delivery, but clinical studies show limited efficacy, emphasizing the need for improved strategies such as combined therapies. In this study, we identified lysosoma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9eecabd4-2b7e-5cf2-9a8d-5beabd018a4c
DOI
10.1101/2025.02.11.637610
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting lysosomal damage is a new therapeutic perspective for Duchenne Muscular DystrophyDOI 10.1101/2025.02.11.637610
Select a neighboring publication to make it the new centre.